This article will provide a comprehensive guide from a pharmacist to anyone on a GLP-1 medication or thinking about starting one
Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis
AOA Clinical Guidance for ODs With GLP-1RA use increasing (15 million users as of 2024) and ophthalmology workforce shortages projected by 2035, ODs are primed to lead ocular monitoring in this area
Upon receipt, keep peptides cold and protected from light
Using strength training, quick sprints, or more intense HIIT prior to longer aerobic exercises can also lessen the hypoglycemia response in those with type 1 diabetes (34)
Meanwhile, other companies looking at combined GLP-1/glucagon agonists include Boehringer Ingelheim and Zealand Pharma, whose survodutide candidate is in phase 3 testing